BioReliance
Company: BioReliance Corporation
Company Description: BioReliance Corporation is a leading contract service organization focused on the rapidly growing biologics sector. Founded in 1947 the Company has operations in the U.S., United Kingdom and Germany. The Company serves over 600 clients annually - including most of the world's largest pharmaceutical, biotechnology and medical device companies.
Nomination Category: Corporate Media Awards Categories
Nomination Sub Category: Best Investor Relations Program
Nomination Title: BioReliance vs. Bioterrorism: Managing Volatility and Communicating Long-term Value in a Period of Hype
N/A
Based in Rockville, MD, BioReliance Corp. provides testing and development and manufacturing services for the production of biologics and other biomedical products. The U.S. Government contracted BioReliance to manufacture quantities of small pox vaccine for an anti-terror program. Instead of taking advantage of this small pox news (and putting the U.S. and its clients at risk), BioReliance chose to maintain a minimum disclosure policy. In a time of increased investor scrutiny and volatility, FRB|Weber Shandwick helped the Company navigate guidance issues, build credibility and achieve program and reputation enhancement goals that would outlast the "small pox" buzz.
Agency/City: FRB|Weber Shandwick Worldwide, New York
Client: BioReliance Corp.
Director: Marilynn Meek, Julie Tu, Susan Garland, Samantha Alphonso, Kerry Thalheim